Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults


  • Picart Thiébaud
  • Barritault Marc
  • Poncet Delphine
  • Berner Lise-Prune
  • Izquierdo Cristina
  • Tabouret Emeline
  • Figarella-Branger Dominique
  • Idbaïh Ahmed
  • Bielle Franck
  • Bourg Véronique
  • Vandenbos Fanny
  • Cohen Elizabeth
  • Moyal Jonathan
  • Uro-Coste Emmanelle
  • Guyotat Jacques
  • Honnorat Jérôme
  • Gabut Mathieu
  • Meyronet David
  • Ducray François


  • Diffuse Hemispheric Glioma
  • H33 G34R/V mutation
  • H33 K27M mutation
  • PNET
  • Survival


Background Diffuse hemispheric gliomas, H3 G34-mutant (DHG H3G34-mutant) constitute a distinct type of aggressive brain tumors. Although initially described in children, they can also affect adults. The aims were to describe the characteristics of DHG H3G34-mutant in adults and to compare them to those of established types of adult WHO grade IV gliomas. Methods The characteristics of 17 adult DHG H3G34-mutant, 32 H3.3 K27M-mutant diffuse midline gliomas (DMG), 100 IDH-wildtype and 36 IDH-mutant glioblastomas were retrospectively analyzed. Results Median age at diagnosis in adult DHG H3G34-mutant was 25 years (range: 19-33). All tumors were hemispheric. For 9 patients (56%), absent or faint contrast enhancement initially suggested another diagnosis than a high-grade glioma, and diffusion-weighted imaging seemed retrospectively more helpful to suspect an aggressive tumor than MR-spectroscopy and perfusion MRI. All cases were IDH-wildtype. Most cases were immunonegative for ATRX (93%) and Olig2 (100%) and exhibited MGMT promoter methylation (82%). The clinical and radiological presentations of adult DHG H3G34-mutant were different from those of established types of adult grade IV gliomas. Median overall survival of adult DHG H3G34-mutant was 12.4 months compared to 19.6 months (p=.56), 11.7 months (p=.45) and 50.5 months (p=0.006) in H3.3 K27M-mutant DMG, IDH-wildtype and IDH-mutant glioblastomas, respectively. Conclusions Adult DHG H3G34-mutant are associated with distinct characteristics compared to those of established types of adult WHO grade IV gliomas. The present study supports considering these tumors as a new type of WHO grade IV glioma in future classifications.

more information